← All companiesEEnlivex Therapeutics Ltd.
ENLV - CIK 0001596812
Enlivex Therapeutics Ltd. net income by year
Enlivex Therapeutics Ltd. (ENLV) reported net income of $1.24B for fiscal year 2025, as filed in its audited annual report with the SEC.
ENLV annual net income
ENLV net income 2012-2025
| Fiscal year | Net Income | Change |
|---|
| FY 2025 | $1.24B | +8329.2% |
| FY 2024 | -$15.01M | +48.3% |
| FY 2023 | -$29.07M | +6.4% |
| FY 2022 | -$31.06M | -114.7% |
| FY 2021 | -$14.47M | -22.4% |
| FY 2020 | -$11.82M | -26.0% |
| FY 2019 | -$9.38M | -121.2% |
| FY 2018 | -$4.24M | -69.4% |
| FY 2017 |
Net Income of similar companies
Frequently asked questions
How much profit does Enlivex Therapeutics Ltd. make?
Enlivex Therapeutics Ltd. (ENLV) reported net income of $1.24B for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Enlivex Therapeutics Ltd.'s net income changed over time?
Between fiscal 2012 and fiscal 2025, Enlivex Therapeutics Ltd.'s net income grew from -$229.00K to $1.24B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.